• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

优化毕赤酵母中重组人乳头瘤病毒 52 型主要衣壳蛋白 L1 的生产。

Optimizing the production of recombinant human papilloma virus type 52 major capsid protein L1 in Hansenula polymorpha.

机构信息

Department of Biotechnology, Faculty of Science, Mahidol University, Bangkok, 10400, Thailand.

出版信息

Sci Rep. 2024 Nov 18;14(1):28555. doi: 10.1038/s41598-024-79764-7.

DOI:10.1038/s41598-024-79764-7
PMID:39558031
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11574089/
Abstract

Cervical cancer is the fourth most prevalent cancer among women globally, with Thai women ranking it as the third most common. At present, a prophylactic vaccine, containing virus-like particles (VLPs) of HPV L1 capsid protein, is widely recognized as one of the major prevention strategies for cervical cancer. Unfortunately, due to a low cross-protection among subtypes, protection against each HPV subtype requires vaccination with VLPs of that specific subtype. This study aimed to optimize the cultivation medium and conditions to maximize the volumetric yield of HPV52 L1 protein produced by the recombinant H. polymorpha HPV52. The results revealed that supplementation of a complex organic nitrogen source HySoy (at 10 g/L) into SYN6 medium resulted in a significantly higher specific HPV52 L1 yield and the maximum specific and volumetric HPV52 L1 protein yield were obtained at 30℃. In this study, the volumetric yield of HPV52 L1 could be increased from 50.9 mg/L in flask-scale cultivation to 2728 mg/L in High Cell Density Cultivation or HCDC (53-folds) with a significant improvement in terms of productivity, from 0.85 mg/L.h in flask-scale cultivation to 22.7 mg/L.h in HCDC (27-folds).

摘要

宫颈癌是全球女性第四大常见癌症,泰国女性将其列为第三大常见癌症。目前,一种包含 HPV L1 衣壳蛋白病毒样颗粒(VLPs)的预防性疫苗被广泛认为是预防宫颈癌的主要策略之一。不幸的是,由于各亚型之间的交叉保护作用较低,每种 HPV 亚型都需要接种该特定亚型的 VLPs 来预防。本研究旨在优化培养介质和条件,以最大限度地提高重组 H. polymorpha HPV52 产生的 HPV52 L1 蛋白的体积产率。结果表明,在 SYN6 培养基中添加复合有机氮源 HySoy(10 g/L)可显著提高 HPV52 L1 的比产率,在 30℃下可获得最大的 HPV52 L1 蛋白比产率和体积产率。在本研究中,HPV52 L1 的体积产率可以从摇瓶培养的 50.9 mg/L 提高到高密度细胞培养(HCDC)中的 2728 mg/L(53 倍),并且在生产力方面有显著提高,从摇瓶培养的 0.85 mg/L.h 提高到 HCDC 中的 22.7 mg/L.h(27 倍)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fa3/11574089/88b0f4f08dcc/41598_2024_79764_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fa3/11574089/8174d41cb239/41598_2024_79764_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fa3/11574089/7b791cf64995/41598_2024_79764_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fa3/11574089/5f7dfe0e927c/41598_2024_79764_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fa3/11574089/d8ce47576cb5/41598_2024_79764_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fa3/11574089/610d71ef4219/41598_2024_79764_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fa3/11574089/fcf03a82ed5e/41598_2024_79764_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fa3/11574089/88b0f4f08dcc/41598_2024_79764_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fa3/11574089/8174d41cb239/41598_2024_79764_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fa3/11574089/7b791cf64995/41598_2024_79764_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fa3/11574089/5f7dfe0e927c/41598_2024_79764_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fa3/11574089/d8ce47576cb5/41598_2024_79764_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fa3/11574089/610d71ef4219/41598_2024_79764_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fa3/11574089/fcf03a82ed5e/41598_2024_79764_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fa3/11574089/88b0f4f08dcc/41598_2024_79764_Fig7_HTML.jpg

相似文献

1
Optimizing the production of recombinant human papilloma virus type 52 major capsid protein L1 in Hansenula polymorpha.优化毕赤酵母中重组人乳头瘤病毒 52 型主要衣壳蛋白 L1 的生产。
Sci Rep. 2024 Nov 18;14(1):28555. doi: 10.1038/s41598-024-79764-7.
2
[Optimized expression of the L1 protein of human papillomavirus in Hansenula polymorpha].[人乳头瘤病毒L1蛋白在多形汉逊酵母中的优化表达]
Sheng Wu Gong Cheng Xue Bao. 2009 Oct;25(10):1516-23.
3
Expression of unique chimeric human papilloma virus type 16 (HPV-16) L1-L2 proteins in Pichia pastoris and Hansenula polymorpha.独特的嵌合人乳头瘤病毒16型(HPV-16)L1-L2蛋白在毕赤酵母和多形汉逊酵母中的表达
Yeast. 2018 Sep;35(9):519-529. doi: 10.1002/yea.3318. Epub 2018 May 24.
4
Production of Recombinant Human Papillomavirus Type 52 L1 Protein in Hansenula polymorpha Formed Virus-Like Particles.在多形汉逊酵母中产生重组人乳头瘤病毒52型L1蛋白并形成病毒样颗粒
J Microbiol Biotechnol. 2015 Jun;25(6):936-40. doi: 10.4014/jmb.1412.12027.
5
Production of human papillomavirus type 33 L1 major capsid protein and virus-like particles from Bacillus subtilis to develop a prophylactic vaccine against cervical cancer.利用枯草芽孢杆菌生产人乳头瘤病毒 33 型 L1 主要衣壳蛋白和病毒样颗粒,以开发预防宫颈癌的疫苗。
Enzyme Microb Technol. 2012 Mar 10;50(3):173-80. doi: 10.1016/j.enzmictec.2011.11.004. Epub 2011 Nov 25.
6
Production of codon-optimized type 52 L1 virus-like particles in BG10 expression system.在 BG10 表达系统中生产优化密码子的 52 型 L1 病毒样颗粒。
Prep Biochem Biotechnol. 2023;53(2):148-156. doi: 10.1080/10826068.2022.2048262. Epub 2022 Mar 18.
7
VLP Production from Recombinant L1/L2 HPV-16 Protein Expressed in Pichia Pastoris.在毕赤酵母中表达的重组L1/L2人乳头瘤病毒16型蛋白生产病毒样颗粒
Protein Pept Lett. 2018;25(8):783-790. doi: 10.2174/0929866525666180809124633.
8
Diverse expression levels of two codon-optimized genes that encode human papilloma virus type 16 major protein L1 in Hansenula polymorpha.在多形汉逊酵母中编码人乳头瘤病毒16型主要蛋白L1的两个密码子优化基因的不同表达水平。
Biotechnol Lett. 2014 May;36(5):937-45. doi: 10.1007/s10529-014-1455-z. Epub 2014 Feb 22.
9
Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.由L1/L2嵌合病毒样颗粒组成的人乳头瘤病毒疫苗在临床前模型中诱导产生广泛的交叉保护作用。
J Virol. 2016 Jun 24;90(14):6314-25. doi: 10.1128/JVI.00449-16. Print 2016 Jul 15.
10
The L1 major capsid protein of human papillomavirus type 16 variants affects yield of virus-like particles produced in an insect cell expression system.人乳头瘤病毒16型变体的L1主要衣壳蛋白影响昆虫细胞表达系统中产生的病毒样颗粒的产量。
J Clin Microbiol. 1998 Jul;36(7):2046-51. doi: 10.1128/JCM.36.7.2046-2051.1998.

本文引用的文献

1
Advances in Using as Chassis for Recombinant Protein Production.利用[具体内容]作为重组蛋白生产底盘的研究进展。 (你提供的原文“Using ”后面似乎缺失了具体信息)
Front Bioeng Biotechnol. 2019 May 1;7:94. doi: 10.3389/fbioe.2019.00094. eCollection 2019.
2
Expression of unique chimeric human papilloma virus type 16 (HPV-16) L1-L2 proteins in Pichia pastoris and Hansenula polymorpha.独特的嵌合人乳头瘤病毒16型(HPV-16)L1-L2蛋白在毕赤酵母和多形汉逊酵母中的表达
Yeast. 2018 Sep;35(9):519-529. doi: 10.1002/yea.3318. Epub 2018 May 24.
3
Production of virus-like particles for vaccines.
用于疫苗的病毒样颗粒的生产。
N Biotechnol. 2017 Oct 25;39(Pt B):174-180. doi: 10.1016/j.nbt.2017.07.010. Epub 2017 Aug 1.
4
Use of Phytone Peptone to Optimize Growth and Cell Density of Lactobacillus reuteri.使用植物蛋白胨优化罗伊氏乳杆菌的生长和细胞密度。
Foods. 2015 Aug 10;4(3):318-327. doi: 10.3390/foods4030318.
5
Production of Recombinant Human Papillomavirus Type 52 L1 Protein in Hansenula polymorpha Formed Virus-Like Particles.在多形汉逊酵母中产生重组人乳头瘤病毒52型L1蛋白并形成病毒样颗粒
J Microbiol Biotechnol. 2015 Jun;25(6):936-40. doi: 10.4014/jmb.1412.12027.
6
Virus-like particle-based human vaccines: quality assessment based on structural and functional properties.基于病毒样颗粒的人用疫苗:基于结构和功能特性的质量评估。
Trends Biotechnol. 2013 Nov;31(11):654-63. doi: 10.1016/j.tibtech.2013.09.002. Epub 2013 Oct 11.
7
The papillomavirus major capsid protein L1.乳头瘤病毒主要衣壳蛋白 L1。
Virology. 2013 Oct;445(1-2):169-74. doi: 10.1016/j.virol.2013.05.038. Epub 2013 Jun 22.
8
Expression of recombinant staphylokinase in the methylotrophic yeast Hansenula polymorpha.在甲醇营养型酵母汉逊德巴利酵母中表达重组葡激酶。
BMC Biotechnol. 2012 Dec 19;12:96. doi: 10.1186/1472-6750-12-96.
9
Expression of codon optimized major capsid protein (L1) of human papillomavirus type 16 and 18 in Pichia pastoris; purification and characterization of the virus-like particles.表达优化密码子的人乳头瘤病毒 16 型和 18 型主要衣壳蛋白(L1);病毒样颗粒的纯化和表征。
Vaccine. 2011 Oct 6;29(43):7326-34. doi: 10.1016/j.vaccine.2011.07.071. Epub 2011 Jul 29.
10
Human papillomavirus oncoproteins: pathways to transformation.人乳头瘤病毒致癌蛋白:转化途径。
Nat Rev Cancer. 2010 Aug;10(8):550-60. doi: 10.1038/nrc2886. Epub 2010 Jul 1.